hyundai pharm co ltd
ASLAN & Hyundai Pharm Collaborate To Develop Cancer Drug
The two companies will conduct clinical trials to assess varlitinib in the treatment of aggressive bile duct cancer, a disease prevalent in South Korea.
The two companies will conduct clinical trials to assess varlitinib in the treatment of aggressive bile duct cancer, a disease prevalent in South Korea.
